Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

NCT06949033 is registered in ClinicalTrials.gov with Zuoyi Jiao as lead sponsor.

NCT NCT06949033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06949033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Lead sponsor
Zuoyi Jiao
Phase
Phase 3
Overall status
Recruiting
Start date
May 15, 2025
Completion date
December 31, 2030
Enrollment
668 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant chemotherapy, gastric cancer (including stomach and gastroesophageal junction [gej]), mpr, neoadjuvant therapy, orr,os,pfs, pcr rate